NurExone Biologic Ltd. is an Israeli biotech company developing treatment to restore function in patients with traumatic CNS damage. NurExone’s approach is based on a proprietary exosome-based technology with intranasal delivery to revolutionize the treatment of acute spinal cord injury (SCI) worldwide.
Read More